Last Posted: Jun-24-2019 11AM
Last Posted: Jun 24, 2019
- [II. Medical Genomics for Breast Cancer].
Aruga Tomoyuki et al. Gan to kagaku ryoho. Cancer & chemotherapy 2018 Dec 45(12) 1716-1719 - Association of CYP2C19*2 and ALDH1A1*1/*2 variants with disease outcome in breast cancer patients: results of a global screening array.
Kalra Sourav et al. European journal of clinical pharmacology 2018 Oct 74(10) 1291-1298 - Addition of a 161-SNP polygenic risk score to family history-based risk prediction: impact on clinical management in non- BRCA1/2 breast cancer families.
Lakeman Inge M M et al. Journal of medical genetics 2019 Jun - Do cancer risk and benefit-harm ratios influence women's consideration of risk-reducing mastectomy? A scenario-based experiment in five European countries.
Rebitschek Felix G et al. PloS one 2019 14(6) e0218188 - Female family members lack understanding of indeterminate negative BRCA1/2 test results shared by probands.
Himes Deborah O et al. Journal of genetic counseling 2019 Jun - Impact of biomarkers and genetic profiling on breast cancer prognostication: A comparative analysis of the 8th edition of breast cancer staging system.
Yoon Esther C et al. The breast journal 2019 Jun - Polygenic prediction of breast cancer: comparison of genetic predictors and implications for risk stratification.
Läll Kristi et al. BMC cancer 2019 Jun 19(1) 557 - Prognostic significance of miR-34 rs4938723 T?>?C polymorphism in triple negative breast cancer patients.
Tsiakou Andriani et al. Clinical biochemistry 2019 Jun 689-14 - Radiomics signature on 3T dynamic contrast-enhanced magnetic resonance imaging for estrogen receptor-positive invasive breast cancers: Preliminary results for correlation with Oncotype DX recurrence scores.
Nam Kyung Jin et al. Medicine 2019 Jun 98(23) e15871 - Risk stratification of ER-positive breast cancer patients: A multi-institutional validation and outcome study of the Rochester Modified Magee algorithm (RoMMa) and prediction of an Oncotype DX ® recurrence score <26.
Turner Bradley M et al. Cancer medicine 2019 Jun
No hay comentarios:
Publicar un comentario